Compare
Xperi Inc. vs Alkami Technology, Inc. vs Via Transportation, Inc. vs Cellebrite DI Ltd.
| Latest fiscal year | Xperi Inc. XPER | Alkami Technology, Inc. ALKT | Via Transportation, Inc. VIA | Cellebrite DI Ltd. CLBT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $448.11M | $443.64M | $434.34M | $475.68M |
| Revenue growth (YoY) | -9.2% | +32.9% | +28.6% | +18.6% |
| Gross margin | n/a | 57.8% | 39.6% | 84.2% |
| Operating margin | -9.8% | -12.1% | -17.6% | 14.0% |
| Net margin | -12.6% | -10.7% | -22.2% | 16.5% |
| Net income | -$56.34M | -$47.65M | -$96.36M | $78.33M |
| EPS (Diluted) | -$1.23 | -$0.46 | -$2.92 | $0.31 |
| Operating cash flow | -$515.0K | $42.91M | -$30.87M | $173.54M |
| Free cash flow | -$5.90M | $41.36M | -$32.53M | $160.32M |
| Cash & equivalents | $96.82M | $63.46M | $370.91M | $124.46M |
| Total assets | $615.83M | $847.23M | $733.10M | $938.85M |
| Total liabilities | $201.75M | $485.18M | $105.36M | $454.53M |
| Shareholders' equity | $414.07M | $362.05M | $627.74M | $484.32M |
| Return on year-end equity | -13.6% | -13.2% | -15.4% | 16.2% |
| Shares outstanding | 46.92M | 106.10M | n/a | 248.58M |
Revenue, most recent five fiscal years
| Fiscal year | Xperi Inc. | Alkami Technology, Inc. | Via Transportation, Inc. | Cellebrite DI Ltd. |
|---|---|---|---|---|
| Latest | $448.11M Ended 2025-12-31 | $443.64M Ended 2025-12-31 | $434.34M Ended 2025-12-31 | $475.68M Ended 2025-12-31 |
| 1 year earlier | $493.69M Ended 2024-12-31 | $333.85M Ended 2024-12-31 | $337.63M Ended 2024-12-31 | $401.20M Ended 2024-12-31 |
| 2 years earlier | $521.33M Ended 2023-12-31 | $264.83M Ended 2023-12-31 | $248.85M Ended 2023-12-31 | $325.11M Ended 2023-12-31 |
| 3 years earlier | $502.26M Ended 2022-12-31 | $204.27M Ended 2022-12-31 | n/a | $270.65M Ended 2022-12-31 |
| 4 years earlier | $486.48M Ended 2021-12-31 | $152.16M Ended 2021-12-31 | n/a | $246.25M Ended 2021-12-31 |